Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

Launched by M.D. ANDERSON CANCER CENTER · Feb 8, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the symptoms and changes that patients experience while receiving treatment for sinonasal (nose and sinus) or nasopharyngeal (throat) cancers. The researchers want to learn how these conditions and their treatments affect patients' daily lives and overall well-being. They are currently looking for patients who are 18 years or older and have either been diagnosed with or are suspected to have these types of tumors. To participate, patients should be planning to receive most of their treatment at MD Anderson Cancer Center.

If you decide to join the trial, you'll be asked to share your experiences and any symptoms you may have during your treatment. It's important to note that patients with a history of other types of cancers (except for certain skin cancers), or those with cognitive issues unrelated to their current condition, are not eligible to participate. Overall, this study aims to gather valuable information that can help improve the care and support for individuals facing these challenging diagnoses.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • 1. Previously untreated patients with or suspected to have sinonasal malignancy or nasopharyngeal malignancy diagnosis based on either outside pathology report or MD Anderson pathology report.
• • 2. Age ≥ 18 years
• • 3. Plan to obtain the majority of treatment at MDACC including surgery and radiotherapy
• • 4. Ability to understand and willingness to sign written informed consent
• Exclusion criteria:
• • 1. History of the previous solid or liquid malignancies, apart from skin cancers treated with local therapy.
• • 2. Existing neurocognitive impairment that is not the result of sinonasal and nasopharyngeal cancers or is treatment.
• • 3. Previous treatment for sinonasal or nasopharyngeal carcinomas, apart from biopsy.